Detailed information for compound 2127514
Basic information
Technical information
- TDR Targets ID: 2127514
- Name: 4'-dimethylamino-4'-phenylspiro[4,9-dihydro-3 H-pyrano[3,4-b]indole-1,1'-cyclohexane]-6-ol
- MW: 376.215 | Formula: C24H28N2O2
-
H donors: 2
H acceptors: 1
LogP: 3.86
Rotable bonds: 2
Rule of 5 violations (Lipinski): 0 - SMILES: Oc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
- InChi: InChI=1S/C24H28N2O2/c1-26(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(27)8-9-21(20)25-22/h3-9,16,25,27H,10-15H2,1-2H3
- InChiKey: KFKGRKGKOJKTPF-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- 4'-dimethylamino-4'-phenyl-spiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,1'-cyclohexane]-6-ol
- 4'-dimethylamino-4'-phenyl-6-spiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,1'-cyclohexane]ol
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | opioid growth factor receptor-like 1 | No references | |
| Homo sapiens | opioid receptor, mu 1 | No references |
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0587 | 0.8607 | 0.8607 |
| Trichomonas vaginalis | ras-dva small GTPase, putative | 0.06 | 0.893 | 1 |
| Echinococcus multilocularis | ras gtpase | 0.06 | 0.893 | 1 |
| Entamoeba histolytica | Ras family GTPase | 0.06 | 0.893 | 1 |
| Loa Loa (eye worm) | Ras protein let-60 | 0.06 | 0.893 | 1 |
| Trichomonas vaginalis | dexras1, putative | 0.06 | 0.893 | 1 |
| Trypanosoma cruzi | lanosterol synthase, putative | 0.0644 | 1 | 1 |
| Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0587 | 0.8607 | 0.5 |
| Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0587 | 0.8607 | 0.5 |
| Trichomonas vaginalis | rap1 and, putative | 0.06 | 0.893 | 1 |
| Echinococcus granulosus | ras gtpase | 0.06 | 0.893 | 1 |
| Trichomonas vaginalis | ral, putative | 0.06 | 0.893 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.06 | 0.893 | 1 |
| Trichomonas vaginalis | rheb, putative | 0.06 | 0.893 | 1 |
| Trichomonas vaginalis | GTP-binding protein rit, putative | 0.06 | 0.893 | 1 |
| Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0587 | 0.8607 | 1 |
| Trypanosoma brucei | lanosterol synthase | 0.0644 | 1 | 1 |
| Trypanosoma cruzi | lanosterol synthase, putative | 0.0644 | 1 | 1 |
| Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0587 | 0.8607 | 0.9639 |
| Brugia malayi | Ras protein let-60 | 0.06 | 0.893 | 1 |
| Brugia malayi | Ras-related protein R-Ras2 | 0.06 | 0.893 | 1 |
| Giardia lamblia | Prenyltransferase | 0.0587 | 0.8607 | 0.5 |
| Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0587 | 0.8607 | 0.8607 |
| Entamoeba histolytica | Ras family GTPase | 0.06 | 0.893 | 1 |
| Leishmania major | farnesyltransferase beta subunit | 0.0587 | 0.8607 | 1 |
| Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0587 | 0.8607 | 0.5 |
| Entamoeba histolytica | ras-1, putative | 0.06 | 0.893 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Ki (binding) | = 1.1 nM | Binding Assay | BINDINGDB. | No reference |
| Ki (binding) | = 1.6 nM | Binding Assay | BINDINGDB. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL3959597
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.